Canary Cure Advances Novel siRNA Therapeutic Targeting Obesity into In Vivo Trials
First-in-Class Gene-Targeted Approach to Promote Fat-Burning, Preserve Lean Body Mass, and Enhance Metabolic Health by Harnessing the Endocannabinoid System
First-in-Class Gene-Targeted Approach to Promote Fat-Burning, Preserve Lean Body Mass, and Enhance Metabolic Health by Harnessing the Endocannabinoid System
White Plains Hospital has been named one of the country’s Best Hospitals in the inaugural Money (formerly Money Magazine) national...
Non-invasive ultra-rapid test delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants Designed for...
CANARY GLOBAL INC.’s PELICAN DIGIGENE™ PLATFORM, WORLD’S FIRST POINT OF CARE, REAL-TIME COVID-19 MUTANT IDENTIFICATION TEST COVID-19 test manufacturer continues...
Non-invasive ultra-rapid test delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants Designed for...
Rapid molecular PCR-like accurate saliva-based test delivers 95% sensitivity and 98% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including...
Canary Global has been accepted into Canada’s SR&ED program which aims to encourage R&D work conducted for the advancement of...